URSOLIGN
NDC 81279-130, ursodiol, capsule, from Pangea Pharmaceuticals, LLC.
- Product NDC
- 81279-130
- Status
- Listed
- Labeler
- Pangea Pharmaceuticals, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210344
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81279-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- URSODIOL150 mg/1
Pharmacologic classes
Bile Acid [EPC]; Bile Acids and Salts [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81279-130-60 | 81279013060 | 60 CAPSULE in 1 BOTTLE (81279-130-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3617fb7a-1f57-4276-bebb-ae6ba4252d4e
Use it
Look up 81279-130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81279-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81279-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.